Published in Hepatitis Weekly, October 16th, 1995
In patients infected with HBV and undergoing orthotopic liver transplantation, the threat of HBV reinfection is great, noted Yaron Ilan and colleagues, Hadassah University Hospital, Jerusalem, Israel.
Ilan et al. report they evaluated their experience with 11 HBsAg positive patients with end-stage liver disease who received liver transplantation ("Long-Term Prevention of Recurrent Hepatitis B Virus after Liver Transplantation," Israel...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1995-10-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.